{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:21:49Z","timestamp":1787437309835,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Beh\u00e7et\u2019s disease (BD) is an inflammatory autoimmune disease characterized by relapsing genital ulcers, ocular involvement, and intestinal disorders. Evaluate serum levels of circular RNA (circRNA) FUNDC1 and tumor necrosis factor-alpha (TNF-\u03b1) in BD patients and compare them accordingly to healthy individuals. One hundred participants were enrolled in this study and subdivided equally into BD patients and healthy matched individuals. A five mL sample of blood was drawn from each subject and analyzed to measure circRNA-FUNDC1 and TNF-\u03b1. Full clinical investigations have been performed, and the Behcet Disease Current-Activity Form score (BDCAF) has been calculated. circRNA-FUNDC1 and TNF-\u03b1 were measured by quantitative real time PCR and enzyme-linked immunosorbent assay (ELISA) respectively. An up-regulation of circRNA-FUNDC1 as well as TNF-\u03b1 (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001) in BD group were reported compared to controls. Both biomarkers tended to elevate with the activity of the disease as levels were higher in active BD patients than inactive patients. The level of circRNA-FUNDC1 (FC) tended to be higher in patients with negative musculoskeletal and central nervous system (CNS) manifestations than those with positive manifestations (p-values\u2009=\u20090.007, 0.037, respectively). The level of TNF-\u03b1 was reported higher in those with oral ulcer with (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.041), also in patients with positive skin manifestations than in negative patients (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.025). The level of circRNA-FUNDC1 (FC) was higher in patients who took Azathioprine and steroids (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.019, 0.035) and lower in patients who took cyclosporin (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.049). TNF-\u03b1 tended to elevate in patients who took Hydroxychloroquine than those who did not (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.040). The upregulated levels of circRNA-FUNDC1 and TNF-\u03b1 may have a potential role in improving our understanding of the molecular mechanisms underlying BD.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-66489-y","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T21:53:22Z","timestamp":1787435602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Upregulation of serum circular RNA FUNDC1 and TNF-\u03b1 in Beh\u00e7et\u2019s disease: potential diagnostic biomarkers"],"prefix":"10.1038","volume":"16","author":[{"given":"Rehab Elsayed","family":"Marzouk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfat G.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Ali","family":"Gameil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine M.","family":"Amrousy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai A.","family":"El Kosaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha O.","family":"Shawky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"issue":"9","key":"66489_CR1","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/ibd\/izad210","volume":"30","author":"R Erfan","year":"2024","unstructured":"Erfan, R. et al. Circulating miR-199a and long noncoding-RNA ANRIL as promising diagnostic biomarkers for inflammatory bowel disease. Inflamm. Bowel Dis. 30(9), 1500\u20131509 (2024).","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"66489_CR2","first-page":"1","volume":"52","author":"JR Iacovino","year":"2025","unstructured":"Iacovino, J. R. The mortality of Behcet\u2019s Disease. J. Insurance Med. (New York N Y) 52(1), 1\u20132 (2025).","journal-title":"J. Insurance Med. (New York N Y)"},{"issue":"1","key":"66489_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13010041","volume":"13","author":"F Alibaz-Oner","year":"2022","unstructured":"Alibaz-Oner, F. & Direskeneli, H. Update on the diagnosis of Beh\u00e7et\u2019s disease. Diagnostics 13(1), 41 (2022).","journal-title":"Diagnostics"},{"issue":"4","key":"66489_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00296-022-05258-2","volume":"43","author":"TA Gheita","year":"2023","unstructured":"Gheita, T. A. et al. Rheumatoid arthritis study of the Egyptian College of Rheumatology (ECR): nationwide presentation and worldwide stance. Rheumatol. Int. 43 (4), 667\u2013676 (2023).","journal-title":"Rheumatol. Int."},{"key":"66489_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.691512","volume":"13","author":"M Zhang","year":"2021","unstructured":"Zhang, M. & Bian, Z. The emerging role of circular RNAs in Alzheimer\u2019s disease and Parkinson\u2019s disease. Front. Aging Neurosci. 13, 691512 (2021).","journal-title":"Front. Aging Neurosci."},{"issue":"7","key":"66489_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41419-019-1744-5","volume":"10","author":"Z Zhou","year":"2019","unstructured":"Zhou, Z., Sun, B., Huang, S. & Zhao, L. Roles of circular RNAs in immune regulation and autoimmune diseases. Cell Death Dis. 10 (7), 503 (2019).","journal-title":"Cell Death Dis."},{"key":"66489_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.846198","volume":"13","author":"J Zu","year":"2022","unstructured":"Zu, J. et al. Circular RNA FUNDC1 for prediction of acute phase outcome and long-term survival of acute ischemic stroke. Front. Neurol. 13, 846198 (2022).","journal-title":"Front. Neurol."},{"issue":"2","key":"66489_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/ncb2422","volume":"14","author":"L Liu","year":"2012","unstructured":"Liu, L. et al. Mitochondrial outer membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat. Cell Biol. 14(2), 177\u2013185 (2012).","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"66489_CR9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/15548627.2016.1151580","volume":"12","author":"M Chen","year":"2016","unstructured":"Chen, M. et al. Mitophagy receptor FUNDC1 regulates mitochondrial dynamics and mitophagy. Autophagy 12 (4), 689\u2013702 (2016).","journal-title":"Autophagy"},{"issue":"1","key":"66489_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrm3028","volume":"12","author":"RJ Youle","year":"2011","unstructured":"Youle, R. J. & Narendra, D. P. Mechanisms of mitophagy. Nat. Rev. Mol. Cell Biol. 12 (1), 9\u201314 (2011).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"66489_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.807654","volume":"12","author":"L Liu","year":"2021","unstructured":"Liu, L., Li, Y. & Chen, Q. The emerging role of FUNDC1-mediated mitophagy in cardiovascular diseases. Front. Physiol. 12, 807654 (2021).","journal-title":"Front. Physiol."},{"issue":"11","key":"66489_CR12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1089\/jir.2023.0097","volume":"43","author":"NAA Hameed","year":"2023","unstructured":"Hameed, N. A. A., Shaker, O. G. & Hasona, N. A. LINC00641\/miR-378a and their cross-talk with TNF-\u03b1\/IFN-\u03b3 as potential biomarkers in ulcerative colitis and Crohn\u2019s diseases. J. Interferon Cytokine Res. 43(11), 531\u2013537 (2023).","journal-title":"J. Interferon Cytokine Res."},{"key":"66489_CR13","first-page":"417","volume":"72","author":"M Mihara","year":"2021","unstructured":"Mihara, M., Hashizume, M., Yoshida, H., Suzuki, M. & Shiina, M. Anti-interleukin-6 receptor antibody therapy for autoimmune diseases. Annu. Rev. Med. 72, 417\u2013434 (2021).","journal-title":"Annu. Rev. Med."},{"key":"66489_CR14","first-page":"41","volume":"18","author":"FU Bakti","year":"2025","unstructured":"Bakti, F. U. & Sufiawati, I. Clinical activity of Behcet\u2019s disease associated with SARS-CoV-2 and herpes simplex virus: Insights from three case reports. Int. Med. Case Rep. J. 18, 41\u201352 (2025).","journal-title":"Int. Med. Case Rep. J."},{"issue":"6","key":"66489_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1089\/jir.2018.0116","volume":"39","author":"NA El Boghdady","year":"2019","unstructured":"El Boghdady, N. A. & Shaker, O. G. Role of serum miR-181b, proinflammatory cytokine, and adhesion molecules in Beh\u00e7et\u2019s disease. J. Interferon Cytokine Res. 39(6), 347\u2013354 (2019).","journal-title":"J. Interferon Cytokine Res."},{"issue":"3","key":"66489_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","author":"International Team for the Revision of the International Criteria for Beh\u00e7et\u2019s Disease (ITR-ICBD)","year":"2014","unstructured":"International Team for the Revision of the International Criteria for Beh\u00e7et\u2019s Disease (ITR-ICBD). The International Criteria for Beh\u00e7et\u2019s disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J. Eur. Acad. Dermatol. Venereol. 28(3), 338\u2013347 (2014).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"6","key":"66489_CR17","first-page":"1467","volume":"18","author":"OG Shaker","year":"2021","unstructured":"Shaker, O. G. et al. MiR-146a and miR-155 polymorphisms in Egyptian patients with Behcet\u2019s disease. Arch. Med. Sci. 18(6), 1467\u20131474 (2021).","journal-title":"Arch. Med. Sci."},{"key":"66489_CR18","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3389\/fimmu.2019.00665","volume":"10","author":"B Tong","year":"2019","unstructured":"Tong, B., Liu, X., Xiao, J. & Su, G. Immunopathogenesis of Beh\u00e7et\u2019s disease. Front. Immunol. 10, 665 (2019).","journal-title":"Front. Immunol."},{"key":"66489_CR19","doi-asserted-by":"crossref","unstructured":"Shaker, O. G. et al. Expression of TNF-\u03b1, APRIL and BCMA in Behcet\u2019s disease. J. Immunol. Res.\u00a02014, 380405 (2014).","DOI":"10.1155\/2014\/380405"},{"key":"66489_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-024-10963-7","author":"R El-Gamal","year":"2024","unstructured":"El-Gamal, R. et al. Evaluation of circANKLE2 & circL3MBTL4 -RNAs expression in fertile and infertile men. Biochem. Genet. https:\/\/doi.org\/10.1007\/s10528-024-10963-7 (2024).","journal-title":"Biochem. Genet."},{"issue":"4","key":"66489_CR21","first-page":"527","volume":"89","author":"M Cort\u00e9s-L\u00f3pez","year":"2016","unstructured":"Cort\u00e9s-L\u00f3pez, M. & Miura, P. Emerging functions of circular RNAs. Yale. J. Biol. Med. 89(4), 527\u2013537 (2016).","journal-title":"Yale. J. Biol. Med."},{"issue":"9","key":"66489_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.699","volume":"5","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Circular RNAs in human diseases. MedComm 5(9), e699 (2024).","journal-title":"MedComm"},{"key":"66489_CR23","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3389\/fimmu.2020.00545","volume":"11","author":"LJ Li","year":"2020","unstructured":"Li, L. J., Leng, R. X., Fan, Y. G., Pan, H. F. & Ye, D. Q. The role of circular RNAs in immune-related diseases. Front. Immunol. 11, 545 (2020).","journal-title":"Front. Immunol."},{"issue":"6","key":"66489_CR24","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","volume":"77","author":"G Hatemi","year":"2018","unstructured":"Hatemi, G. et al. 2018 update of the EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome. Ann. Rheum. Dis. 77 (6), 808\u2013818 (2018).","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"66489_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s42358-023-00328-w","volume":"63","author":"D Hu","year":"2023","unstructured":"Hu, D. & Guan, J. L. The roles of immune cells in Beh\u00e7et\u2019s disease. Adv. Rheumatol. (London England). 63 (1), 49 (2023).","journal-title":"Adv. Rheumatol. (London England)"},{"issue":"1","key":"66489_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/ijms25010178","volume":"25","author":"X Li","year":"2023","unstructured":"Li, X., Yang, L. & Chen, L. L. Circular RNAs: Promising treatment targets and biomarkers of ischemic stroke. Int. J. Mol. Sci. 25(1), 178 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"66489_CR27","first-page":"136117","volume":"761","author":"Y Wang","year":"2021","unstructured":"Wang, Y., Zhang, H., Liu, W., Wang, L. & Zhang, X. Knockdown of circFUNDC1 alleviates OGD-induced injury in human brain microvascular endothelial cells via the miR-375\/PTEN axis. Neurosci. Lett. 761, 136117 (2021).","journal-title":"Neurosci. Lett."},{"issue":"1","key":"66489_CR28","first-page":"1","volume":"21","author":"AM El-Shafey","year":"2014","unstructured":"El-Shafey, A. M., El-Mawla, A., Elsawy, E. M. & M. A., & Serum levels of TNF-alpha and its\u2009\u2013\u2009308 G\/A polymorphism in Egyptian patients with Beh\u00e7et\u2019s disease. Egypt. J. Immunol. 21 (1), 1\u201310 (2014).","journal-title":"Egypt. J. Immunol."},{"issue":"1\u20132","key":"66489_CR29","first-page":"27","volume":"146","author":"A G\u00fcl","year":"2012","unstructured":"G\u00fcl, A. et al. Elevated serum levels of TNF-\u03b1 in Beh\u00e7et\u2019s disease: A key cytokine in pathogenesis? Immunol. Lett. 146 (1\u20132), 27\u201331 (2012).","journal-title":"Immunol. Lett."},{"issue":"2","key":"66489_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00296-002-0191-1","volume":"22","author":"AA Shahin","year":"2002","unstructured":"Shahin, A. A. et al. Circulating interleukin-6, soluble interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-10 levels in juvenile chronic arthritis: correlations with soft tissue vascularity assessed by power Doppler sonography. Rheumatol. Int. 22 (2), 84\u201388 (2002).","journal-title":"Rheumatol. Int."},{"issue":"1","key":"66489_CR31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s43166-023-00172-2","volume":"50","author":"KI El-Noueam","year":"2023","unstructured":"El-Noueam, K. I., El-Gazzar, B. A., El-Wakd, M. M. & El-Shereef, R. R. Functional disability among Beh\u00e7et\u2019s disease patients: its relation to fatigue, depression, anxiety, and quality of life. Egypt. Rheumatol. Rehabilitation. 50 (1), 6 (2023).","journal-title":"Egypt. Rheumatol. Rehabilitation"},{"key":"66489_CR32","doi-asserted-by":"crossref","first-page":"724900","DOI":"10.3389\/fimmu.2021.724900","volume":"12","author":"U Tursen","year":"2021","unstructured":"Tursen, U., Tursen, B. & Lotti, T. Pathophysiology of Beh\u00e7et\u2019s disease. Front. Immunol. 12, 724900 (2021).","journal-title":"Front. Immunol."},{"issue":"1","key":"66489_CR33","first-page":"4749","volume":"24","author":"S Koseoglu","year":"2024","unstructured":"Koseoglu, S., Hatipoglu, M. & Han, B. Elevated TNF-\u03b1 levels in gingival crevicular fluid of Beh\u00e7et\u2019s disease patients with active oral ulcers. BMC Oral Health. 24 (1), 4749 (2024).","journal-title":"BMC Oral Health"},{"key":"66489_CR34","doi-asserted-by":"publisher","first-page":"724900","DOI":"10.3389\/fimmu.2021.724900","volume":"12","author":"S \u00c7imen","year":"2021","unstructured":"\u00c7imen, S. & Y\u0131ld\u0131r\u0131m, A. Saliva and serum cytokine profiles during oral ulceration in Beh\u00e7et\u2019s disease. Front. Immunol. 12, 724900 (2021).","journal-title":"Front. Immunol."},{"issue":"2","key":"66489_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrrheum.2017.208","volume":"14","author":"H Yazici","year":"2018","unstructured":"Yazici, H., Seyahi, E., Hatemi, G. & Yazici, Y. Beh\u00e7et syndrome: A contemporary view. Nat. Rev. Rheumatol. 14 (2), 107\u2013119 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"66489_CR36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mito.2017.10.009","volume":"41","author":"J Harris","year":"2018","unstructured":"Harris, J., Deen, N., Zamani, S. & Hasnat, M. A. Mitophagy and the release of inflammatory cytokines. Mitochondrion 41, 2\u20138 (2018).","journal-title":"Mitochondrion"},{"key":"66489_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.918943","volume":"10","author":"N Tan","year":"2022","unstructured":"Tan, N. et al. The multi-faced role of FUNDC1 in mitochondrial events and human diseases. Front. Cell Dev. Biol. 10, 918943 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"66489_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.788634","volume":"9","author":"G Li","year":"2021","unstructured":"Li, G., Li, J., Shao, R., Zhao, J. & Chen, M. FUNDC1: A promising mitophagy regulator at the mitochondria-associated membrane for cardiovascular diseases. Front. Cell Dev. Biol. 9, 788634 (2021).","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66489-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66489-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66489-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:05:23Z","timestamp":1787436323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66489-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["66489"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-66489-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"27 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A written informed consent was acquired from every participant.","order":1,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study approval was obtained from the Faculty of Medicine, Mansoura University, with approval code R.24.08.2752 on 23\/10\/2024.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26368"}}